Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G
Uppsala University Children's Hospital, Sweden.
Acta Paediatr. 2000 Jul;89(7):814-9.
We recorded the incidence and degree of posterior subcapsular cataract (PSC) in 29 children who had undergone autologous (n = 28) or syngeneic (n = 1) bone marrow transplantation (BMT) due to haematologic or lymphoid malignancy. Conditioning prior to transplantation consisted either of a combination of chemotherapy and total body irradiation (TBI) (n = 21) or of chemotherapy only (n = 8). TBI was given in one fraction of 7.5 Gy. Nine patients had received previous cranial irradiation. The patients were followed for 4-10y (median 8 y) after transplantation. Of 29 patients, 22 developed PSC, all within 4 y after BMT. With the exception of one patient who developed unilateral PSC, all had received TBI. Conversely, 100% of those who received TBI developed PSC. In this group (+TBI), eight patients (38%) developed significant PSC, defined as best corrected visual acuity <0.8 in either eye. Six patients (10 eyes) have since needed surgical repair consisting of extracapsular cataract extraction and intraocular lens implantation. There was no clear relationship between previous cranial irradiation and cataract development, nor any other obvious baseline differences between those in the +TBI group who developed significant PSC and those who did not. Although effects of previous therapy cannot be ruled out, TBI appears to be the main cause of PSC in this group of patients. Twelve patients in the +TBI group had well-preserved visual acuity throughout the study, reflecting a slow progression of PSC. This compares favourably with previous reports of allogeneic BMT, possibly owing to less need for corticosteroids after autologous BMT. We conclude that the incidence of PSC was high after autologous BMT where the conditioning regimen included total body irradiation.
我们记录了29例因血液系统或淋巴系统恶性肿瘤接受自体(n = 28)或同基因(n = 1)骨髓移植(BMT)的儿童后囊下白内障(PSC)的发生率和程度。移植前的预处理包括化疗和全身照射(TBI)联合(n = 21)或仅化疗(n = 8)。TBI以7.5 Gy单次剂量给予。9例患者先前接受过颅脑照射。患者在移植后随访4 - 10年(中位8年)。29例患者中,22例发生PSC,均在BMT后4年内。除1例发生单侧PSC的患者外,所有患者均接受了TBI。相反,接受TBI的患者100%发生了PSC。在该组(+TBI)中,8例患者(38%)发生了显著PSC,定义为任何一只眼睛的最佳矫正视力<0.8。此后,6例患者(10只眼)需要进行包括囊外白内障摘除和人工晶状体植入的手术修复。先前的颅脑照射与白内障发生之间没有明确关系,在发生显著PSC的+TBI组患者和未发生显著PSC的患者之间也没有任何其他明显的基线差异。尽管不能排除先前治疗的影响,但TBI似乎是该组患者PSC的主要原因。+TBI组中有12例患者在整个研究过程中视力保持良好,这反映了PSC的进展缓慢。这与先前关于同种异体BMT的报道相比具有优势,可能是由于自体BMT后对皮质类固醇的需求较少。我们得出结论,在预处理方案包括全身照射的自体BMT后,PSC的发生率很高。